Abstract
In Minneapolis, Minnesota, on October 16 to 18, 2009, the fourth “International Summit on the Diagnosis and Management of Hypertrophic Cardiomyopathy and Prevention of Sudden Death: The Next 50 Years,” was held and sponsored by the Minneapolis Heart Institute Foundation in recognition of the fiftieth Anniversary of this disease (Figure 1). During the previous half-century, hypertrophic cardiomyopathy (HC) persistently intrigued and challenged the cardiovascular community and, indeed, has periodically been the source of misunderstanding and even controversy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.